BeOne Medicines Ltd.
ONC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 14 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $9.93B in total; no superinvestor holds it.
Other share classesBEIGF
13F holders, Q2 2026
Institutional positions in BeOne Medicines Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 283
- +4 vs. Q1 2026
- Shares held
- 35.0M
- +157.3K (+0.5%) vs. Q1 2026
- Total value
- $9.93B
- −$398.8M (−3.9%) vs. Q1 2026
- New holders
- 45
- 124 more added
- Sold out
- 41
- 68 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 283 | $9.93B |
| Q1 2026 | 282 | $10.3B |
| Q4 2025 | 288 | $10.3B |
| Q3 2025 | 266 | $11.2B |
| Q2 2025 | 245 | $8.34B |
| Q1 2025 | 268 | $11.6B |
| Q4 2024 | 229 | $8.07B |
| Q3 2024 | 228 | $10.4B |
| Q2 2024 | 200 | $6.68B |
| Q1 2024 | 205 | $7.27B |
| Q4 2023 | 204 | $8.11B |
| Q3 2023 | 201 | $8.46B |
| Q2 2023 | 209 | $8.39B |
| Q1 2023 | 220 | $10.3B |
| Q4 2022 | 214 | $10.9B |
| Q3 2022 | 223 | $7.22B |
| Q2 2022 | 235 | $8.67B |
| Q1 2022 | 238 | $10.4B |
| Q4 2021 | 263 | $15.0B |
| Q3 2021 | 255 | $20.4B |
| Q2 2021 | 268 | $19.1B |
| Q1 2021 | 253 | $19.5B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding BeOne Medicines Ltd.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −1,503−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Sageworth Trust Co | 0 | $0 | 0.00% | −1,470−100.0% | Sold out |
| Knollwood Investment Advisory, LLC | 0 | $0 | 0.00% | −1,111−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −882−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −707−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −683−100.0% | Sold out |
| Abacus Wealth Partners, LLC | 0 | $0 | 0.00% | −679−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −676−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Golden State Equity Partners | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Hager Investment Management Services, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Wealth Science Advisors LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| JPL Wealth Management, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Legacy Wealth Managment, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Westside Investment Management, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Albion Financial Group | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Skopos Labs, Inc. | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| Evelyn Partners Investment Management LLP | – | – | – | – | Not filed |